What is the Current Research and Future Directions?
Research is ongoing to better understand how checkpoint inhibitors can be used most effectively in gynecologic cancers. This includes studies on combination therapies, such as using checkpoint inhibitors alongside chemotherapy, radiation, or other targeted therapies. Researchers are also looking at ways to identify new biomarkers that can predict response and reduce side effects.
